Effects of Roflumilast on Patients with Chronic Obstructive Pulmonary Disease Treated with Inhaled Corticosteroid/Long-Acting β2 Agonist: A Meta-analysis

Figure 7

Comparison of incidence of adverse reactions between the roflumilast group and placebo group (no difference).